Michael Carson
Director of Finance/CFO at NUVECTIS PHARMA, INC.
Net worth: 59 241 $ as of 2024-04-29
Profile
Michael J.
Carson is currently the Chief Financial Officer at Nuvectis Pharma, Inc. Prior to his current position, he held the role of Director-Financial Planning & Analysis at Neuronetics, Inc. from 2015 to 2019.
He also worked as an Auditor at Crowe LLP and Deloitte Consulting LP.
Additionally, Michael served as the Vice President-Finance & Global Controller at Smiths Medical, Inc. and as the Vice President-Finance at Xylocor Therapeutics, Inc. from 2019 to 2021.
He obtained his undergraduate degree from Lafayette College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NUVECTIS PHARMA, INC.
0.05% | 2023-04-23 | 9,100 ( 0.05% ) | 59 241 $ | 2024-04-29 |
Michael Carson active positions
Companies | Position | Start |
---|---|---|
NUVECTIS PHARMA, INC. | Director of Finance/CFO | 2022-03-20 |
Former positions of Michael Carson
Companies | Position | End |
---|---|---|
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Director of Finance/CFO | 2020-12-31 |
NEURONETICS, INC. | Corporate Officer/Principal | 2018-12-31 |
Deloitte Consulting LP
Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Comptroller/Controller/Auditor | - |
Smiths Medical, Inc. | Director of Finance/CFO | - |
Crowe LLP
Crowe LLP Miscellaneous Commercial ServicesCommercial Services Crowe LLP provides accounting services. The firm offers audit, tax, advisory, risk, and performance services. It serves banking, manufacturing, media and telecommunication, construction, real estate, financial, food, commodities and healthcare industries. The company was founded by Fred P. Crowe Sr. and Cletus F. Chizek in 1942 and is headquartered in South Bend, IN. | Comptroller/Controller/Auditor | - |
Training of Michael Carson
Lafayette College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NEURONETICS, INC. | Health Technology |
Private companies | 5 |
---|---|
Crowe LLP
Crowe LLP Miscellaneous Commercial ServicesCommercial Services Crowe LLP provides accounting services. The firm offers audit, tax, advisory, risk, and performance services. It serves banking, manufacturing, media and telecommunication, construction, real estate, financial, food, commodities and healthcare industries. The company was founded by Fred P. Crowe Sr. and Cletus F. Chizek in 1942 and is headquartered in South Bend, IN. | Commercial Services |
Smiths Medical, Inc. | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Health Technology |
Deloitte Consulting LP
Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Commercial Services |
Nuvectis Pharma, Inc. |
- Stock Market
- Insiders
- Michael Carson